Review of Deep Learning Based Autosegmentation for Clinical Target Volume: Current Status and Future Directions

CONCLUSIONS: DLAS demonstrates capability of completing CTV contour plans with increased efficiency and accuracy. However, most models are developed and validated by single institutions using guidelines followed by the developing institutions. Publications about DLAS of the CTV have increased in recent years. Future studies and DLAS models need to include larger data sets with different patient demographics, disease stages, validation in multi-institutional settings, and inclusion of dosimetric performance.PMID:38550365 | PMC:PMC10966174 | DOI:10.1016/j.adro.2024.101470
Source: Adv Data - Category: Epidemiology Authors: Source Type: research